Videos
Advanced Ovarian Cancer
HER2+ BC: Residual Disease After Neoadjuvant Therapy
Bassel El-Rayes, MD, discusses the key points physicians should consider when treating a patient with metastatic colorectal cancer.
Early HER2+ Breast Cancer
Multiple Myeloma
Noopur Raje, MD, discusses the current treatment options for patients diagnosed with multiple myeloma. At this time, a number of FDA-approved drugs and different combinations are available.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Tarlatamab Shows Activity in SCLC With Brain Metastases in Real-World Cohort
2
Generic Larotrectinib Capsules Gain Tentative FDA Approval
3
FDA Grants Rare Pediatric Disease Designation to Opaganib for Neuroblastoma
4
ASCO 2026 Highlights: Breast & Lung Cancer Advances With Ajaz Khan, MD
5